Trial Profile
Dose optimization of tacrolimus using Bayesian prediction including pharmacogenetic variables in renal transplant patients.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 Jul 2016
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Transplant rejection
- Focus Pharmacokinetics
- Acronyms OPTIMUS
- 11 Jul 2016 New trial record